This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return ...

Alkermes ALKS announced positive top-line data from the phase II Vibrance-1 study, which evaluated its novel, investigational ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Johnson & Johnson JNJ announced that it has submitted a new drug application (NDA) to the FDA seeking approval for its ...